Parkinson’s disease: Binghamton researchers develop new drug that may treat and limit progression

Researchers at Binghamton University have developed a new drug that may limit the progression of Parkinson's disease while providing better symptom relief to potentially hundreds of thousands of people with the disease. Symptoms of Parkinson's disease are commonly managed using a selective dopamine receptor agonists. While these drugs are useful in early-stage Parkinson's, they tend ["]

The post Parkinson's disease: Binghamton researchers develop new drug that may treat and limit progression appeared first on Outbreak News Today.